Structure-Based Discovery and Characterization of a Preclinical Drug Candidate for the Treatment of HIV-1 Infection

HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs) area key component of the current HIV-1 combination drug regimens. Although they exhibit potent anti-HIV-1 activity and modest toxicity, the emergence of mutant strains limits their application in clinical. Our previous research efforts...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Dongwei, Yang, Jinxuan, Kong, Lingjin, Luo, Ronghua, Huang, Xusheng, Zhang, Tao, Ma, Mengdi, Feng, Da, Wang, Zhao, Fang, Hao, Zhan, Peng, Zheng, Yongtang, Liu, Xinyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699427/
https://www.ncbi.nlm.nih.gov/pubmed/36366488
http://dx.doi.org/10.3390/v14112390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699427/
https://www.ncbi.nlm.nih.gov/pubmed/36366488
http://dx.doi.org/10.3390/v14112390

Ejemplares similares